Fly News Breaks for March 2, 2015
OPK
Mar 2, 2015 | 11:52 EDT
Ladenburg raised its price target for OPKO Health shares to $18.50 following the company's "uneventful" Q4 results. The firm sees reduced risk of near-term dilution given the $295M upfront payment from Pfizer. It keeps a Buy rating on the stock.
News For OPK From the Last 2 Days
There are no results for your query OPK